What do systematic reviews say?

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Unfractionated heparin vs low molecular weight heparin

The review found no eligible studies for this question.

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Heparin vs placebo

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 40 participants
  Low

Heparin vs placebo

The review found no eligible studies for this question.

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Heparin vs placebo

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 40 participants
  Low

Unfractionated heparin vs low molecular weight heparin

It is very uncertain whether unfractionated heparin changes DVT (symptomatic, asymptomatic, non‐fatal) (5 to 8 days after surgery) compared with low molecular weight heparin (very low certainty).

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  OR 1.23 [0.28, 5.35]
  1 study · 75 participants
  Very low

Unfractionated heparin vs low molecular weight heparin

The review found no eligible studies for this question.

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Unfractionated heparin vs low molecular weight heparin

The review found no eligible studies for this question.

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Unfractionated heparin vs low molecular weight heparin

The review found no eligible studies for this question.

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Unfractionated heparin vs low molecular weight heparin

The review found no eligible studies for this question.

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Heparin vs placebo

The review found no eligible studies for this question.

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Heparin vs placebo

The review found no eligible studies for this question.

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Heparin vs placebo

Heparin showed no clear difference in PE (symptomatic, asymptomatic, non‐fatal) (timing not specified) compared with placebo (low certainty).

• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity 2020 · Cochrane Headline outcomes only
  OR 0.84 [0.35, 2.01]
  1 study · 134 participants
  Low

Hypertonic saline vs other intracranial pressure‐lowering agents

It is very uncertain whether hypertonic saline changes mortality (short‐term) compared with other intracranial pressure‐lowering agents (very low certainty).

• Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury 2020 · Cochrane Headline outcomes only
  RR 0.33
  2 studies · 70 participants
  Very low

Hypertonic saline vs other intracranial pressure‐lowering agents

It is very uncertain whether hypertonic saline changes mortality at 6 months compared with other intracranial pressure‐lowering agents (very low certainty).

• Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury 2020 · Cochrane Headline outcomes only
  RR 0.84 [0.46, 1.55]
  2 studies · 85 participants
  Very low

Hypertonic saline vs other intracranial pressure‐lowering agents

It is very uncertain whether hypertonic saline changes glasgow Outcome Scale: poor outcome at 6 months compared with other intracranial pressure‐lowering agents (very low certainty).

• Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury 2020 · Cochrane Headline outcomes only
  RR 1.09 [0.82, 1.44]
  2 studies · 85 participants
  Very low

Hypertonic saline vs other intracranial pressure‐lowering agents

• Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury 2020 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 287 participants
  Very low

Hypertonic saline vs other intracranial pressure‐lowering agents

• Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 32 participants
  Very low

Hypertonic saline vs other intracranial pressure‐lowering agents

The review found no eligible studies for this question.

• Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found